{"id":"W3047097799","doi":"10.1038/s43018-020-0096-5","title":"Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab","year":2020,"lang":"en","type":"article","venue":"Nature Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":480,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; Ontario Institute for Cancer Research; Public Health Ontario; University of Toronto; University Health Network","funders":"Department of Medical Biophysics, University of Toronto; Canada Research Chairs; Terry Fox Research Institute; Canada Foundation for Innovation; Princess Margaret Cancer Foundation","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Biomarker; Circulating tumor DNA; Clinical trial; Response Evaluation Criteria in Solid Tumors; Immunotherapy; Immune checkpoint; Cancer; Phases of clinical research; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003998446,0.0002190916,0.0003032629,0.00008718165,0.00004967398,0.00002931321,0.0001418003,0.0001601025,0.00007577884],"category_scores_gemma":[0.0001580744,0.0001912575,0.0001402685,0.000609762,0.000064321,0.000005132385,0.00006260248,0.0002278169,0.000002508903],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001484586,"about_ca_system_score_gemma":0.0003466823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002641471,"about_ca_topic_score_gemma":0.0004323978,"domain_scores_codex":[0.9987566,0.00003244252,0.0002051973,0.0005372531,0.000197072,0.0002714068],"domain_scores_gemma":[0.9993257,0.00001551586,0.0001405624,0.00018128,0.0001894074,0.0001475217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00893355,0.0003281386,0.8383672,0.0001338801,0.003039629,0.0002201966,0.00104948,0.009452672,0.1355978,0.0001011752,0.001662057,0.00111426],"study_design_scores_gemma":[0.01856516,0.002217664,0.8832575,0.0002105279,0.001808003,0.00001967403,0.0003833982,0.007870184,0.07357253,0.00005459893,0.01057402,0.001466741],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966488,0.001788773,0.00008451096,0.0002348255,0.00005718435,0.0003023603,0.0003169045,0.00001409907,0.0005525665],"genre_scores_gemma":[0.9965906,0.00007936427,0.00006761889,0.002621392,0.0001364138,0.00008871563,0.0003538436,0.00003377069,0.00002832652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06202525,"threshold_uncertainty_score":0.7799255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006281876612736395,"score_gpt":0.256241797350765,"score_spread":0.2499599207380286,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}